Beckman Coulter today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test demonstrated 99.9% specificity with 1,400 ...
The outbreak of 2019 novel coronavirus disease (Covid-19) caused by SARS-CoV-2 has spread rapidly, inducing a progressive growth in infected patients number. Social isolation (lockdown) has been ...
The current COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus that causes severe acute respiratory distress in a significant proportion of ...
Some manufacturers tested the cross‑reactivity of their products with antibodies against different pathogens, but none of them tested antibodies against other coronaviruses. In almost all cases, ...
Earlier this year, The New York Times’ science and health reporter Donald G McNeil Jnr made some predictions about the unfolding pandemic: that the United States would suffer from a shortage of ...
The quantitative range and reproducibility of current serological tests for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are not optimized. Herein, we developed a diagnostic test that ...
The time component is so important here, because if you test somebody that’s on day 5 of a COVID-19 infection, they are unlikely to be mounting a significant IgG or IgM response. It’s not until about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results